DWN12088 ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
85	特発性間質性肺炎	4

85. 特発性間質性肺炎

---

臨床試験数 : 627 /  薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05389215 (ClinicalTrials.gov)	July 29, 2022	17/4/2022	Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF	A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DWN12088 in Patients With Idiopathic Pulmonary Fibrosis	Idiopathic Pulmonary Fibrosis	Drug: DWN12088;Drug: Placebo	Daewoong Pharmaceutical Co. LTD.	NULL	Recruiting	40 Years	N/A	All	102	Phase 2	United States;Korea, Republic of
2	NCT04888715 (ClinicalTrials.gov)	July 23, 2021	28/4/2021	To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers	An Open Label, 2-part, One-sequence, 3-period Study to Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers	Idiopathic Pulmonary Fibrosis	Drug: DWN12088;Drug: Pirfenidone;Drug: Nintedanib	Daewoong Pharmaceutical Co. LTD.	NULL	Completed	19 Years	55 Years	All	48	Phase 1	Korea, Republic of
3	NCT04888728 (ClinicalTrials.gov)	June 30, 2021	28/4/2021	To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers	An Open Label, 2-part, One-sequence, 3-period Study to Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Male Volunteers	Idiopathic Pulmonary Fibrosis	Drug: DWN12088;Drug: Nebivolol;Drug: Paroxetine	Daewoong Pharmaceutical Co. LTD.	NULL	Completed	20 Years	55 Years	Male	24	Phase 1	Korea, Republic of
4	NCT04767815 (ClinicalTrials.gov)	March 22, 2021	15/2/2021	To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers	A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers	Idiopathic Pulmonary Fibrosis	Drug: Diet A group;Drug: Diet B group;Drug: Diet C group	Daewoong Pharmaceutical Co. LTD.	NULL	Completed	19 Years	55 Years	All	36	Phase 1	Korea, Republic of